Clearside Biomedical, Inc. — Director's Dealing 2019

Apr 10, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2019-04-07

Reporting Person: LASEZKAY GEORGE M (Director, Interim CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-07	Stock Option (right to buy)	$1.40	A	250000	Acquired	2029-04-06	Common Stock (250000)	Direct

Footnotes

F1: The shares underlying this option vest in six equal monthly installments beginning on May 7, 2019.